Internal Medicine, Rheumatology · Charleston, SC
NPI
1205247137
Since 2014
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
171 Ashley Ave
Charleston, SC, 29425
Phone (843) 792-1414
Groups this clinician bills Medicare through
Medicare paid, 2024
$99K
4,961 services
Medicare patients, 2024
198
Average age 71
Drug cost, 2024
$3.4M
1,019 prescriptions
Company payments, 2025
$145
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Grace Suppa was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 164 times for 89 patients. In total Grace Suppa billed 4,961 services in 40 codes, and Medicare paid $99K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-17.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 164 | 89 | $11.74 | $1,926 |
| 99214 Office E&M - Established | Office | 124 | 72 | $80.23 | $9,949 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 87 | 50 | $11.80 | $1,027 |
| 99214 Office E&M - Established | Facility | 73 | 43 | $65.30 | $4,767 |
| 99215 Office E&M - Established | Office | 58 | 35 | $107.26 | $6,221 |
| 99215 Office E&M - Established | Facility | 17 | 14 | $99.59 | $1,693 |
| 99204 Office E&M - New | Office | 17 | 17 | $107.48 | $1,827 |
| 99205 Office E&M - New | Office | 15 | 15 | $131.82 | $1,977 |
| 99204 Office E&M - New | Facility | 13 | 13 | $91.96 | $1,196 |
By year: 2022 $33K for 408 services; 2023 $67K for 1,922 services; 2024 $99K for 4,961 services.
Medicare prescription drug claims, 2024
In 2024, the drug Grace Suppa prescribed most often to Medicare patients was Prednisone, with 95 prescriptions and refills. In total Grace Suppa wrote 1,019 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 95 | 164 | 45 | $695 |
| Humira(Cf) Pen Adalimumab | 85 | 98 | 15 | $727K |
| Methotrexate Methotrexate Sodium | 83 | 135 | 20 | $1,562 |
| Enbrel Sureclick Etanercept | 79 | 99 | 13 | $678K |
| Hydroxychloroquine Sulfate Generic | 77 | 149 | 22 | $3,325 |
| Allopurinol Generic | 60 | 146 | 13 | $671 |
| Orencia Clickject Abatacept | 37 | 38 | Under 11 | $193K |
| Alendronate Sodium Generic | 30 | 55 | Under 11 | $226 |
| Actemra Actpen Tocilizumab | 29 | 45 | Under 11 | $203K |
| Cosentyx Sensoready Pen Secukinumab | 23 | 23 | Under 11 | $139K |
| Kevzara Sarilumab | 20 | 26 | Under 11 | $90K |
| Enbrel Etanercept | 20 | 20 | Under 11 | $148K |
| Methotrexate Sodium Methotrexate Sodium/Pf | 20 | 28 | Under 11 | $269 |
| Easy Touch Alcohol Prep Pads Alcohol Antiseptic Pads | 17 | 19 | Under 11 | $23.24 |
| Colchicine Generic | 17 | 35 | Under 11 | $661 |
Brand drugs: 450 claims; generic drugs: 552 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Grace Suppa $145 ($145 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $112.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.